Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Elsley Insider Profile
4 Followers
David Elsley, President & Chief Executive Officer at Cardiol Therapeutics, holds 1.15M shares in Cardiol Therapeutics (Ticker: CRDL).
David Elsley Cardiol Therapeutics (CRDL)President & Chief Executive Officer
Cardiol Therapeutics (CRDL)
President & Chief Executive Officer
Ranked #29,734 out of 98,743 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+15.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & Chief Executive Officer
Roles that David Elsley holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 06, 2020 - Jun 06, 2021
Return:+46.80%
The most profitable trade made by David Elsley
David Elsley's Trading History
List of latest transactions for each holding click on a transaction to see David Elsley's performance on stock
You May Also Like
David Elsley insider profile FAQ
What is the percentage of profitable transactions made by David Elsley?
The percentage of profitable transactions made by David Elsley is 67%.
What is the average return per transaction made by David Elsley?
The average return per transaction made by David Elsley is 15.90%.
What stocks does David Elsley hold?
David Elsley holds: CRDL stocks.
What was David Elsley’s latest transaction?
David Elsley latest transaction was an Uninformative Sell of ―.
What was David Elsley's most profitable transaction?
David Elsley’s most profitable transaction was an Informative Buy of CRDL stock on June 6, 2020. The return on the trade was 46.80%.
What is David Elsley's role in Cardiol Therapeutics?
David Elsley's role in Cardiol Therapeutics is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.